Abbvie Inc (NYSE: ABBV) is 10.40% higher on its value in year-to-date trading and has touched a low of $136.30 and a high of $207.32 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABBV stock was last observed hovering at around $174.43 in the last trading session, with the day’s loss setting it -3.34%.
Currently trading at $171.09, the stock is -11.02% and -11.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.49 million and changing -1.91% at the moment leaves the stock -4.36% off its SMA200. ABBV registered 23.45% gain for a year compared to 6-month gain of 5.88%. The firm has a 50-day simple moving average (SMA 50) of $194.1376 and a 200-day simple moving average (SMA200) of $178.85855.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -12.55% loss in the last 1 month and extending the period to 3 months gives it a -11.35%, and is -15.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.42% over the week and 2.08% over the month.
Abbvie Inc (ABBV) has around 50000 employees, a market worth around $302.34B and $55.53B in sales. Current P/E ratio is 59.67 and Fwd P/E is 14.11. Profit margin for the company is 9.15%. Distance from 52-week low is 25.53% and -17.48% from its 52-week high. The company has generated returns on investments over the last 12 months (7.87%).
with sales reaching $14.81B over the same period.The EPS is expected to shrink by -1.61% this year, but quarterly earnings will post 3.20% year-over-year. Quarterly sales are estimated to grow 3.60% in year-over-year returns.
Abbvie Inc (ABBV) Top Institutional Holders
4232.0 institutions hold shares in Abbvie Inc (ABBV), with institutional investors hold 73.50% of the company’s shares. The shares outstanding are 1.77B, and float is at 1.77B with Short Float at 1.03%. Institutions hold 73.43% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 170.66 million shares valued at $29.27 billion. The investor’s holdings represent 9.6472% of the ABBV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 136.43 million shares valued at $23.4 billion to account for 7.7124 of the shares outstanding. The other top investors are STATE STREET CORP which holds 77.8 million shares representing 4.398% and valued at over $13.34 billion, while JPMORGAN CHASE & CO holds 3.0276 of the shares totaling 53.56 million with a market value of $9.19 billion.
Abbvie Inc (ABBV) Insider Activity
#####
Abbvie Inc disclosed in a document filed with the SEC on Aug 05 ’24 that GONZALEZ RICHARD A (EXECUTIVE CHAIRMAN OF BOARD) sold a total of 66,500 shares of the company’s common stock. The trade occurred on Aug 05 ’24 and was made at $186.52 per share for $12.4 million. Following the transaction, the insider now directly holds 0.45 million shares of the ABBV stock.
Still, SEC filings show that on Aug 07 ’24, Hudson Thomas J (Officer) Proposed Sale 101,886 shares at an average price of $187.62 for $19.12 million. The insider now directly holds shares of Abbvie Inc (ABBV).
